PERC Nepal is actively contributing to ending the AIDS epidemic by designing and implementing innovative programs and interventions. These efforts address the numerous challenges faced by populations affected by HIV. The PERC team has been deeply involved in assessing the public health burden, from psychosocial and mental health issues to drug resistance, among key populations and people living with HIV. In addition to assessment, the team evaluates existing programs and interventions targeting key and vulnerable populations. This evaluation aims to modify or introduce highly effective interventions that align with achieving global targets to end AIDS and viral hepatitis. The focus also extends to measuring the burden of common, curable sexually transmitted infections (STIs) such as syphilis and gonorrhea among key populations. PERC supports the design and implementation of targeted programs to address these burdens effectively. Below are some notable projects and publications from the PERC team that highlight their contributions to addressing these critical health issues.
Dr. Keshab Deuba, the Senior Health Advisor at PERC, received funding in 2009/2010 through the Netherlands Development Organization (SNV) and the Social Inclusion Research Fund (SIRF), Nepal, supported by the Norwegian Embass...
Read More
Biological and Behavioral Surveillance (BBS) surveys are essential for tracking key indicators among populations at higher risk of HIV, including people who inject drugs, men who have sex with men, transgender individuals, se...
Read MoreAsia Pacific Journal of Public Health. April 2012
https://pubmed.ncbi.nlm.nih.gov/22500041/%20PLoS ONE. March 2013
http://www.ncbi.nlm.nih.gov/pubmed/23516434%20BMC Infectious Diseases. December 2013
http://www.ncbi.nlm.nih.gov/pubmed/24369908%20Asian Pac J of Trop Dis. February 2014.
http://www.sciencedirect.com/science/article/pii/S2222180814606885Adv Infect Dis. 2021 Jan-Dec; 8: 20499361211062107 Abstract Background: People who inject drugs (PWID) are at great risk of HIV and Hepatitis C Virus (HCV). In order to properly design interventions and develop programmes for women who inject drugs, this study assessed the prevalence of HIV, Hepatitis B, Hepatitis C, and syphilis and its...
https://pmc.ncbi.nlm.nih.gov/articles/PMC8646840/International Journal of Drug Policy. September 2023. Volume 119, 104145
https://doi.org/10.1016/j.drugpo.2023.1041452024. BMC Health Services Research
https://pubmed.ncbi.nlm.nih.gov/39138448/%20
Our PARTNERS